Induction of nuclear factor-kappa B by exposure to ozone and inhibition by glucocorticoids.
Chung
K F
KF
National Heart and Lung Institute, Imperial College School of Medicine, London, United Kingdom.
Adcock
I M
IM
D000818:Animals; D019743:Chemokines, CXC; D002630:Chemotactic Factors / Q000235:genetics; D003907:Dexamethasone / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects*; D005938:Glucocorticoids / Q000494:pharmacology*; D006133:Growth Substances / Q000235:genetics; D007249:Inflammation; D036341:Intercellular Signaling Peptides and Proteins; D008070:Lipopolysaccharides / Q000494:pharmacology; D008168:Lung / Q000187:drug effects* / Q000378:metabolism; D016328:NF-kappa B / Q000235:genetics*; D009687:Nuclear Proteins / Q000187:drug effects / Q000378:metabolism; D010126:Ozone / Q000037:antagonists & inhibitors / Q000494:pharmacology*; D051381:Rats; D011914:Rats, Inbred BN; D020133:Reverse Transcriptase Polymerase Chain Reaction / Q000379:methods; D014158:Transcription, Genetic / Q000187:drug effects
D019743:Chemokines, CXC; D002630:Chemotactic Factors; D005938:Glucocorticoids; D006133:Growth Substances; D036341:Intercellular Signaling Peptides and Proteins; D008070:Lipopolysaccharides; D016328:NF-kappa B; D009687:Nuclear Proteins; D010126:Ozone; D003907:Dexamethasone